Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Open in API
Filings indexed 749 across all filing types
Latest filing 2019-08-12 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed communication from SMS Pharmaceuticals Limited dated 12th August 2019, addressed to stock exchanges and listing compliance departments. It announces the outcome of a Board Meeting held on the same day. The key points include approval of standalone and consolidated unaudited financial results for the quarter ended 30th June 2019 along with a Limited Review Report, re-appointments and appointment of independent directors, and resignation of an independent director. The document includes detailed financial data for the quarter ended 30th June 2019, such as revenue, expenses, and profit figures, which are typical of quarterly financial results. The presence of unaudited financial results for a quarter and the limited review report strongly indicate this is an Interim / Quarterly Report. The document is not merely an announcement of a report but contains substantive financial data and director changes, which aligns with the definition of an Interim / Quarterly Report (IR). Therefore, the correct classification is IR with high confidence. Q1 2020
2019-08-12 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 68 characters) and contains no substantive content, only placeholders and an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2019-08-05 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 68 characters) and contains no substantive content, financial data, or any report-related information. It only includes placeholders and an omitted picture note. There is no indication of any report, announcement, or filing type. Given the lack of content, the document cannot be classified as any specific report or announcement. According to the rules, such minimal or empty content defaults to Regulatory Filings (RNS) as a fallback category.
2019-08-05 English
Updates
Regulatory Filings
2019-07-25 English
Trading Window
Regulatory Filings
2019-07-01 English
Related Party Transactions
Remuneration Information Classification · 85% confidence The document contains detailed tables listing key management personnel, their relationships, remuneration, and transactions with related parties such as associate companies and enterprises with significant influence. The content focuses on disclosures related to management remuneration and related party transactions, which are typically part of remuneration or governance disclosures. The document length is short (1539 characters), and it does not contain full financial statements or comprehensive financial performance data. It is not an announcement or a certification but a detailed report on management remuneration and related party dealings. Given the focus on remuneration details of key management personnel, the most appropriate classification is Remuneration Information (DEF 14A).
2019-06-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.